Preventing COVID-19 Collateral Damage.

Clin Infect Dis

Yale University School of Medicine, New Haven, Connecticut, USA.

Published: September 2020

AI Article Synopsis

  • The lockdown due to COVID-19 may negatively affect efforts to control other infectious diseases.
  • There's a need to combine COVID-19 responses with current public health initiatives.
  • By doing this, both the fight against COVID-19 and other infectious diseases can be strengthened.

Article Abstract

The lockdown in response to coronavirus disease 2019 (COVID-19) risks damaging the response to many infectious diseases. We recommend integrating the COVID-19 response into existing public health programs, strengthening both.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337641PMC
http://dx.doi.org/10.1093/cid/ciaa772DOI Listing

Publication Analysis

Top Keywords

preventing covid-19
4
covid-19 collateral
4
collateral damage
4
damage lockdown
4
lockdown response
4
response coronavirus
4
coronavirus disease
4
disease 2019
4
2019 covid-19
4
covid-19 risks
4

Similar Publications

In Spain, the agricultural sector relies heavily on migrant workers, especially during seasonal seasons. However, these workers face significant challenges related to precarious working conditions and structural vulnerability, which have become more acute since the outbreak of the COVID-19 pandemic. This descriptive qualitative study was based on 87 personal interviews with health and social professionals from sectors such as NGOs, social services, trade unions, local institutions, and health services to promote compliance with these measures in four Spanish regions.

View Article and Find Full Text PDF

Background: Candida auris (C. auris) is an emerging fungus pathogen associated with nosocomial infections that is seen as a serious global health issue.

Aim: To describe the epidemiology and features of hospital-acquired Candida auris outbreaks in the Ministry of Health hospitals (MOH).

View Article and Find Full Text PDF

SARS-CoV-2 has continued spreading around the world in recent years since the initial outbreak in 2019, frequently developing into new variants with greater human infectious capacity. SARS-CoV-2 and its mutants use the angiotensin-converting enzyme 2 (ACE2) as a cellular entry receptor, which has triggered several therapeutic strategies against COVID-19 relying on the use of ACE2 recombinant proteins as decoy receptors. In this work, we propose an ACE2 silent Fc fusion protein (ACE2-hFcLALA) as a candidate therapy against COVID-19.

View Article and Find Full Text PDF

Background: There is a paucity of research regarding COVID-19 vaccines administration errors (VAEs) during the COVID-19 pandemic. This study aimed to investigate the prevalence, types, severity, causes and predictors of VAEs in Jordan during the recent pandemic.

Method: This was a 3-day (Sunday, Tuesday and Thursday of the third week of November 2021) prospective, covert observational point prevalence study.

View Article and Find Full Text PDF

Porcine epidemic diarrhea virus (PEDV) is a significant pathogen affecting swine, causing severe economic losses worldwide. This study explores the regulatory role of miRNA-328-3p to ZO-1 expression and its impact on PEDV proliferation via the PLC-β1-PKC pathway in IPEC-J2 cells. We found that miRNA-328-3p can target ZO-1, influencing its expression and subsequently affecting the integrity of tight junctions in the cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!